学术周报 · IF≥10

护理领域文献阅读汇编

2026年第41周 (2026-10-08) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选≥10 · 完整摘要不截断
收录论文
22
临床研究
13
基础研究
9
IF≥20
4
IF 10-20
18
子领域
12
期刊种类
15
数据日期
2026-10-08

★本周 Top 10 高影响力文献

#论文期刊IF
1Reducing the burden of heat-related impacts on cardiovascular health.European heart journalIF 45.3
2Impact of Undertreated Antithrombotic Therapy on Adverse Patient Outcomes: A Scientific Statement Fr...CirculationIF 41.3
3Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer.GutIF 24.6
4Gas therapeutics for wound healing: Therapeutic potential of oxygen and nitric oxide.Advanced drug delivery reviewsIF 21.0
5Placebo Pain Relief: Mechanisms and Therapeutic Opportunities.Annual review of pharmacology and toxicologyIF 19.0
6Evaluation of the Bridge-in, Objective, Preassessment, Participatory Learning, Postassessment, and S...JMIR medical educationIF 13.9
7The relationship between palliative psychiatry and assisted dying: a scoping review.EClinicalMedicineIF 12.8
8Colonoscopy quality indicators among nurse endoscopists and physicians in population-based colorecta...EndoscopyIF 11.8
9Rational design of a genetically encoded fluorescent biosensor for real-time and bidirectional detec...Biosensors & bioelectronicsIF 11.8
10Catheter-Associated Urinary Tract Infection Prevention Practices in US Hospitals.JAMA network openIF 11.7

Ŧ期刊分布统计

期刊篇数IF
Acta biomaterialia3IF 10.4
JAMA network open3IF 11.7
British journal of anaesthesia3IF 10.3
Advanced healthcare materials2IF 11.0
Endoscopy1IF 11.8
Advanced drug delivery reviews1IF 21.0
European heart journal1IF 45.3
Gut1IF 24.6
Annual review of pharmacology and toxicology1IF 19.0
JMIR medical education1IF 13.9

1疼痛/姑息护理 (5篇)

基础研究 (5篇)

Annual review of pharmacology and toxicology IF 19.0 2026-10-05 PMID: 42832786
The placebo effect has accompanied medicine throughout its history and remains a powerful modulator of health and disease. While the rise of double-blind, randomized, placebo-controlled trials has positioned placebo effects primarily as methodological controls, accumulating evidence has prompted a reassessment of their underlying mechanisms and therapeutic value. Over the past several decades, substantial progress has been made in elucidating the psychological, neural circuit, and molecular bases of placebo effects. In this review, we summarize recent clinical and preclinical findings that reveal how cognitive processes engage endogenous pain-modulatory circuits to shape pain perception. We further discuss strategies for leveraging placebo-related mechanisms in current clinical practice and outline potential future directions in which a more precise mechanistic understanding may enable targeted, ethical, and effective approaches to pain management.
中文摘要:安慰剂效应在医学历史中始终如影随形,并且仍然是健康和疾病的一种强大调节因素。尽管双盲、随机、安慰剂对照试验的兴起主要将安慰剂效应定位为方法学对照,但不断积累的证据促使人们重新评估其潜在机制和治疗价值。在过去几十年中,阐明安慰剂效应的心理学、神经回路和分子基础方面已取得重大进展。在这篇综述中,我们总结了近期临床和临床前研究结果,这些结果揭示了认知过程如何调动内源性疼痛调节回路来塑造疼痛感知。我们进一步讨论了在当前临床实践中利用安慰剂相关机制的策略,并概述了未来的潜在方向,在这些方向中,更精确的机制理解可能促成靶向、合乎伦理且有效的疼痛管理方法。
Materials horizons IF 11.4 2026-10-01 PMID: 42825798
Pain is a simple yet effective self-defense mechanism in humans that enables rapid responses to harmful stimuli. The inability to sense pain increases the risk of injury due to delayed reactions to such stimuli. However, current prostheses often struggle to differentiate between sensory and pain-like signals and require complex systems to achieve this functionality. In this study, we developed an artificial receptor capable of detecting both sensory and pain-like signals with the threshold discrimination and memory functions intrinsically embedded in the transistor. This functionality was realized by stacking two organic semiconductors and selecting appropriate gate electrodes to achieve multi-threshold and selective memory functions. Integrating these fabricated devices as artificial receptors into prosthetics can significantly enhance patient safety by enabling pain detection while simultaneously reducing fabrication costs.
中文摘要:疼痛是人类一种简单而有效的自我保护机制,使人体能够对有害刺激作出快速反应。无法感知疼痛会因对此类刺激反应延迟而增加受伤风险。然而,当前的假肢往往难以区分感觉信号与疼痛样信号,并且需要复杂系统才能实现该功能。在本研究中,我们开发了一种人工受体,能够检测感觉信号和疼痛样信号,并将阈值辨别和记忆功能内在嵌入晶体管中。该功能通过堆叠两种有机半导体并选择合适的栅电极来实现多阈值和选择性记忆功能而实现。将这些制备的器件作为人工受体集成到假肢中,可通过实现疼痛检测同时显著降低制造成本,从而大幅提高患者安全性。
Acta biomaterialia IF 10.4 2026-10-01 PMID: 42822747
Trigeminal neuralgia is a debilitating neuropathic disorder characterized by the complex interplay of peripheral demyelination and central sensitization. Current pharmacotherapies remain palliative, limited by systemic toxicity and an inability to reverse pathological microenvironments. Herein, an injectable hydrogel integrating analgesic and nerve-repair functions is engineered using thermosensitive hydroxypropyl chitin (HPCH) and oxidized chondroitin sulfate (OCS) to encapsulate microcrystalline carbamazepine (CBZ) for targeted neuro-restoration. Upon perineural injection, the hydrogel precursor undergoes a swift in situ sol-gel transition via dual-crosslinking network formation, intimately enveloping injured nerve fibers to create a stable, bioactive depot. This system executes a spatiotemporally coordinated biphasic intervention: rapid CBZ release provides immediate analgesia by blocking voltage-gated sodium channels, while the bioactive OCS matrix subsequently remodels the local inflammatory microenvironment, downregulating pro-inflammatory cytokines, and guides prolonged regeneration of compact myelin sheaths, which may help restore peripheral nerve insulation and reduce ephaptic transmission. Crucially, in vivo local field potential recordings in the spinal trigeminal nucleus caudalis demonstrate that CBZ@HPCH/OCS treatment attenuated injury-associated gamma-band (30-80 Hz) hyperactivity. This multimodal paradigm integrates rapid pharmacological inhibition with sustained biological repair to effectively alleviate neuropathic pain with no obvious treatment-associated histopathological abnormalities observed in the examined major organs at 14 days post-treatment. STATEMENT OF SIGNIFICANCE: Trigeminal neuralgia causes excruciating facial pain, yet current oral treatments often provide only temporary relief while causing significant systemic toxicity. This study introduces an injectable hydrogel integrating analgesic and nerve-repair functions that transitions from liquid to solid at body temperature for targeted therapy. Unlike traditional drugs that merely mask symptoms, this dual-action system delivers immediate analgesia while actively repairing damaged myelin sheaths. This structural restoration effectively attenuated injury-associated gamma-band hyperactivity and alleviated neuropathic pain. By integrating rapid pharmacological action with long-term biological repair, this work offers a localized, low-toxicity paradigm for chronic pain management, representing a significant advance for researchers in biomaterials, neuroscience, and clinical pain therapy.
中文摘要:三叉神经痛是一种致残性神经病理性疾病,其特征是周围脱髓鞘与中枢敏化的复杂相互作用。当前药物治疗仍属姑息性,受限于全身毒性和无法逆转病理微环境。在此,我们利用热敏羟丙基壳聚糖(HPCH)和氧化硫酸软骨素(OCS)封装微晶卡马西平(CBZ),构建了一种整合镇痛与神经修复功能的可注射水凝胶,用于靶向神经修复。神经周围注射后,水凝胶前体通过双交联网络形成迅速发生原位溶胶-凝胶转变,紧密包裹受损神经纤维,形成稳定且具有生物活性的储库。该系统执行时空协调的双相干预:CBZ快速释放通过阻断电压门控钠通道提供即时镇痛,而具有生物活性的OCS基质随后重塑局部炎症微环境,下调促炎细胞因子,并引导致密髓鞘的长期再生,这可能有助于恢复周围神经绝缘并减少旁触传递。关键的是,在三叉神经脊束核尾侧亚核进行的体内局部场电位记录显示,CBZ@HPCH/OCS治疗减弱了损伤相关的γ波段(30-80 Hz)过度活动。这种多模式策略将快速药理抑制与持续生物修复相结合,有效缓解神经病理性疼痛,且在治疗后14天检查的主要器官中未观察到明显的治疗相关组织病理学异常。意义声明:三叉神经痛引起剧烈的面部疼痛,然而当前口服治疗往往仅提供暂时缓解,同时造成显著的全身毒性。本研究引入一种整合镇痛与神经修复功能的可注射水凝胶,其在体温下从液体转变为固体,用于靶向治疗。与传统仅掩盖症状的药物不同,这种双作用系统在提供即时镇痛的同时主动修复受损髓鞘。这种结构修复有效减弱了损伤相关的γ波段过度活动并缓解了神经病理性疼痛。通过将快速药理作用与长期生物修复相结合,这项工作为慢性疼痛管理提供了一种局部、低毒性的范式,代表了生物材料、神经科学和临床疼痛治疗领域研究者的重要进展。
Acta pharmacologica Sinica IF 10.4 2026-10 PMID: 42463919
Occipital neuralgia (ON) is a refractory chronic headache disorder characterized by paroxysmal shooting or stabbing pain in the posterior scalp, innervated by occipital nerves that originate from C2 and C3 dorsal root ganglion (DRG) neurons. Limited access to human DRG samples has impeded the understanding of the cellular and molecular mechanisms and the development of effective treatments for ON. We innovatively employed percutaneous full-endoscopic C2 ganglionectomy and subsequently performed single-nucleus RNA-sequencing (snRNA-seq) on C2 DRG from both ON patients and healthy controls. Somatostatin-expressing (SST+) neurons were selectively downregulated in patients with ON. Behavioral studies demonstrated that ablation of SST+ neurons induced pain, while optogenetic or chemogenetic activation of these neurons alleviated acute and chronic pain in mice. Altogether, this study provides new insights into the mechanisms underlying ON, revealing potential therapeutic targets for pain management.
中文摘要:枕神经痛(ON)是一种难治性慢性头痛疾病,其特征为后枕部发作性射击样或针刺样疼痛,由起源于C2和C3背根神经节(DRG)神经元的枕神经支配。获取人体DRG样本受限,阻碍了对ON细胞和分子机制的理解及有效治疗方法的开发。我们创新性地采用经皮全内镜下C2神经节切除术,随后对ON患者和健康对照者的C2 DRG进行单核RNA测序(snRNA-seq)。表达生长抑素(SST+)的神经元在ON患者中选择性下调。行为学研究证明,消融SST+神经元会诱发疼痛,而光遗传学或化学遗传学激活这些神经元可缓解小鼠的急性和慢性疼痛。总之,本研究为ON的机制提供了新见解,揭示了疼痛管理的潜在治疗靶点。
Biosensors & bioelectronics IF 11.8 2026-10-01 PMID: 42161117
The μ-opioid receptor (MOR) is a key therapeutic target for pain management. However, robust tools for real-time bidirectional monitoring of MOR activation remain limited. Here, we report GEgMOR, a genetically encoded fluorescent biosensor developed via a rational design strategy combining artificial intelligence (AlphaFold3) with genetic engineering. This strategy drastically reduced the number of required mutant constructs from thousands to merely 239, markedly enhancing the efficiency and precision of biosensor development. GEgMOR exhibits outstanding performance in live-cell assays, with a maximum fluorescence response (ΔF/F0 = 472.8%) 8.6-fold higher than the current state-of-the-art MOR sensor, nanomolar affinity (EC50 = 39.67 nM), rapid kinetics (τon ≈ 1.7 s, τoff ≈ 4.9 s) and high opioid specificity, and excellent photostability under both one-photon and two-photon excitation. Further validation in SH-SY5Y and PC12 neuronal cell models confirmed that the core functional properties of GEgMOR are well maintained in a neuronal cellular context. Notably, GEgMOR enables the first real-time, continuous, and bidirectional monitoring of MOR conformational changes upon agonist activation and antagonist inhibition in a single system. This overcomes the limitations of discontinuous, indirect readouts in conventional stepwise assays. Beyond serving as a powerful dynamic MOR imaging tool, this biosensor establishes a scalable cell-based platform for MOR ligand profiling and drug candidate screening. Our work not only provides a powerful imaging and functional analysis tool for MOR research but also establishes a generalizable strategy to accelerate G protein-coupled receptor (GPCR) biosensor development and advance drug discovery.
中文摘要:μ-阿片受体(MOR)是疼痛管理的重要治疗靶点。然而,用于实时双向监测MOR激活的稳健工具仍然有限。在此,我们报道了GEgMOR,一种通过结合人工智能(AlphaFold3)与基因工程的理性设计策略开发的基因编码荧光生物传感器。该策略将所需突变构建体数量从数千个大幅减少至仅239个,显著提高了生物传感器开发的效率与精准度。GEgMOR在活细胞实验中表现出卓越性能,其最大荧光响应(ΔF/F0 = 472.8%)比当前最先进的MOR传感器高8.6倍,具有纳摩尔级亲和力(EC50 = 39.67 nM)、快速动力学(τon ≈ 1.7 s,τoff ≈ 4.9 s)、高阿片特异性,并且在单光子和双光子激发下均具有优异的光稳定性。在SH-SY5Y和PC12神经元细胞模型中的进一步验证证实,GEgMOR的核心功能特性在神经元细胞环境中得到良好保持。值得注意的是,GEgMOR首次实现了在单一系统中对激动剂激活和拮抗剂抑制下MOR构象变化的实时、连续和双向监测。这克服了传统分步实验中不连续、间接读数的局限性。除作为强大的动态MOR成像工具外,该生物传感器还建立了一个可扩展的基于细胞的平台,用于MOR配体分析和候选药物筛选。我们的工作不仅为MOR研究提供了强大的成像和功能分析工具,还建立了一种可推广的策略,以加速G蛋白偶联受体(GPCR)生物传感器的开发并推进药物发现。

2伤口/造口护理 (4篇)

临床研究 (1篇)

Advanced healthcare materials IF 11.0 2026-10-01 PMID: 42817755
Chronic wounds remain a major healthcare challenge because persistent inflammation, biofilm formation, oxidative stress, protease imbalance, hypoxia, and impaired angiogenesis prevent progression through normal healing. Conventional wound dressings provide passive protection but cannot continuously monitor the dynamic wound microenvironment or deliver adaptive therapy. Unlike previous reviews that independently summarize wound biosensors, responsive biomaterials, or drug-delivery systems, this review critically integrates the complete closed-loop paradigm of intelligent wound management, from single- and multi-stimuli-responsive sensing to AI-assisted autonomous therapeutic intervention. Chemical and physical sensing modalities are comparatively evaluated based on analytical performance, selectivity, clinical readiness, and translational limitations, while multi-responsive logic-gated platforms are assessed against conventional single-stimulus systems. The review further synthesizes available human clinical evidence, compares fabrication strategies and manufacturing scalability, and discusses regulatory pathways governing combination products, Software as a Medical Device, and AI-enabled wound care. Particular emphasis is placed on AI model development, data quality, validation, bias mitigation, and cybersecurity requirements for safe clinical deployment. Finally, major barriers including material scalability, long-term biocompatibility, sensor robustness, standardized clinical validation, and regulatory governance are critically analyzed to establish a translational framework for developing clinically reliable, intelligent smart bandages capable of precision management of chronic wounds.
中文摘要:慢性伤口仍是重大医疗挑战,因为持续炎症、生物膜形成、氧化应激、蛋白酶失衡、缺氧和血管生成受损阻碍其进入正常愈合进程。传统伤口敷料提供被动保护,但无法连续监测动态伤口微环境或提供适应性治疗。与既往分别总结伤口生物传感器、响应性生物材料或药物递送系统的综述不同,本综述批判性整合了智能伤口管理的完整闭环范式,从单一和多刺激响应性传感,到人工智能辅助的自主治疗干预。基于分析性能、选择性、临床就绪度和转化局限,对化学和物理传感模式进行比较评价,同时将多响应逻辑门控平台与传统的单一刺激系统进行对比评估。本综述进一步综合现有的人体临床证据,比较制造策略和生产可扩展性,并讨论组合产品、作为医疗器械的软件以及人工智能赋能伤口护理的监管路径。特别强调人工智能模型开发、数据质量、验证、偏倚缓解和网络安全要求,以实现安全的临床部署。最后,批判性分析材料可扩展性、长期生物相容性、传感器稳健性、标准化临床验证和监管治理等主要障碍,以建立转化框架,用于开发能够精准管理慢性伤口的临床可靠智能绷带。

基础研究 (3篇)

Advanced drug delivery reviews IF 21.0 2026-10-07 PMID: 42843565
Chronic wounds continue to pose a major clinical and socioeconomic challenge, affecting millions of patients worldwide. Their persistence is often driven by impaired oxygenation, persistent infection, biofilm formation, and dysregulated inflammation, all of which disrupt the normal healing cascade. In recent years, gas-based therapeutics particularly oxygen (O₂) and nitric oxide (NO) have attracted considerable attention for their multifaceted roles in tissue repair. Oxygen is essential for cellular metabolism, angiogenesis, and collagen deposition, whereas NO modulates vascular tone, coordinates immune responses, and provides potent antimicrobial activity. This review systematically examines the molecular mechanisms by which O₂ and NO individually and synergistically regulate all four phases of wound healing with particular emphasis on the signalling that link oxygen availability to NO biosynthesis. The challenges related to delivery, dosage, and stability persist. Importantly, a growing body of evidence highlights the biochemical interplay between O₂ and NO, where oxygen stabilizes NO synthesis, and NO mediates oxygen signalling pathways, particularly in angiogenesis and immune modulation. This interdependence suggests that combined O₂-NO delivery may offer superior therapeutic outcomes compared to single-gas approaches. Advances in biomaterials, nanotechnology, and smart dressing design now enable the development of dual-delivery systems capable of controlled and sustained release. Future work should focus on personalized wound care strategies, integration of dual gas therapies with conventional modalities, and large-scale clinical validation to translate biology into practice.
中文摘要:慢性伤口持续构成重大的临床和社会经济挑战,影响全球数百万患者。其迁延不愈通常由氧合受损、持续感染、生物膜形成和炎症失调驱动,这些因素均会破坏正常愈合级联。近年来,基于气体的治疗,尤其是氧气(O₂)和一氧化氮(NO),因其在组织修复中的多重作用而受到广泛关注。氧气对细胞代谢、血管生成和胶原沉积至关重要,而NO可调节血管张力、协调免疫反应并提供强效抗菌活性。本综述系统探讨O₂和NO单独及协同调控伤口愈合全部四个阶段的分子机制,特别强调将氧可利用性与NO生物合成联系起来的信号传导。递送、剂量和稳定性相关的挑战仍然存在。重要的是,越来越多证据强调O₂与NO之间的生化相互作用,其中氧气稳定NO合成,而NO介导氧信号通路,尤其是在血管生成和免疫调节中。这种相互依赖性提示,与单气体策略相比,O₂-NO联合递送可能带来更优的治疗结局。生物材料、纳米技术和智能敷料设计的进展,现已能够开发可控制且持续释放的双重递送系统。未来工作应聚焦于个体化伤口护理策略、将双气体疗法与传统方式整合,以及大规模临床验证,以将生物学转化为实践。
Advanced healthcare materials IF 11.0 2026-10-01 PMID: 42820317
Antibacterial hydrogel microneedles (HMNs) have emerged as promising wound-care platforms by integrating the therapeutic versatility of hydrogels with the minimally invasive tissue penetration of microneedles. This review summarizes recent advances in antibacterial HMNs, focusing on the interplay among material composition, structural architecture, antibacterial mechanisms, and wound-specific therapeutic requirements. Natural and synthetic polymers, together with functional modification and composite strategies, are discussed in relation to mechanical integrity, biocompatibility, and drug-loading capacity. Antibacterial strategies, including antibiotic delivery, metal ion-mediated activity, photothermal therapy (PTT) and photodynamic therapy (PDT), reactive oxygen species (ROS) regulation, antimicrobial peptides (AMPs), and biofilm-targeted approaches, are further examined from the perspectives of antibacterial mechanisms and biosafety. In addition, fabrication strategies and wound-specific applications are systematically reviewed. Based on these advances, a pathology-oriented design framework is proposed to guide the rational coordination of material selection, functionalization, structural engineering, and spatiotemporally controlled delivery. Finally, key challenges in biosafety, standardized evaluation, scalable manufacturing, sterilization, and clinical translation are discussed. This review provides a framework for the rational development of clinically relevant and multifunctional antibacterial HMNs for advanced wound management.
中文摘要:抗菌水凝胶微针(HMNs)通过将水凝胶的治疗多功能性与微针的微创组织穿透性相结合,已成为有前景的伤口护理平台。本综述总结了抗菌HMNs的最新进展,重点探讨材料组成、结构构筑、抗菌机制与伤口特异性治疗需求之间的相互作用。天然与合成聚合物,以及功能化修饰和复合策略,均围绕机械完整性、生物相容性和载药能力进行讨论。抗菌策略,包括抗生素递送、金属离子介导活性、光热疗法(PTT)和光动力疗法(PDT)、活性氧(ROS)调控、抗菌肽(AMPs)及靶向生物膜的方法,进一步从抗菌机制和生物安全性角度进行审视。此外,系统综述了制备策略和伤口特异性应用。基于这些进展,提出了以病理为导向的设计框架,以指导材料选择、功能化、结构工程和时空可控递送的合理协调。最后,讨论了生物安全性、标准化评价、可扩展制造、灭菌和临床转化方面的关键挑战。本综述为合理开发具有临床相关性和多功能抗菌HMNs以用于先进伤口管理提供了框架。
Acta biomaterialia IF 10.4 2026-10 PMID: 42679978
Diabetic wounds are highly susceptible to bacterial infection and exhibit impaired healing largely driven by defective neutrophil function. Herein, we developed an immunomodulatory hydrogel hybridized with a diselenide-bridged polymer (HHD) to regulate neutrophil fate for effective wound management. HHD demonstrates stepwise, glucose- and ROS-responsive drug release. The initially released l-arginine and pyridoxamine improve wound microenvironment by promoting angiogenesis and suppressing advanced glycation end products. Upon infection, this remodeled microenvironment enhances the recruitment and antibacterial capacity of neutrophils, enabling diabetic wounds to regain the ability to form early inflammatory zones and promptly clear invasive bacteria. Furthermore, excessive ROS generated from antimicrobial immunity degrades neutrophil-targeted polymers, releasing an NLRP3 inhibitor that suppresses inflammasome overactivation and accelerates neutrophil apoptosis, thereby facilitating macrophage efferocytosis to initiate tissue repair. We tracked HHD-shaped neutrophils and confirmed their efficacy in preventing infection and accelerating wound healing. Collectively, HHD represents a promising treatment platform for neutrophil-dependent diabetic wound care. STATEMENT OF SIGNIFICANCE: Neutrophil dysfunction is a key factor leading to infection and impaired healing of diabetic wounds. Significant challenges remain in achieving comprehensive regulation of neutrophil fate. In this work, we construct an immunomodulatory composite hydrogel to regulate neutrophil fate in diabetic wounds: 1) Improving the wound microenvironment, enhancing neutrophil recruitment, and strengthening its antibacterial activity; 2) Inducing neutrophil apoptosis through the neutrophil-targeting polymer; 3) Facilitating macrophage efferocytosis and phenotypic switching via apoptotic neutrophils, thereby expediting tissue repair.
中文摘要:糖尿病伤口极易发生细菌感染,且愈合受损,这在很大程度上由中性粒细胞功能缺陷驱动。在此,我们开发了一种与二硒键桥联聚合物(HHD)杂化的免疫调节水凝胶,用于调控中性粒细胞命运以实现有效的伤口管理。HHD具有分步、葡萄糖和ROS响应性药物释放。最初释放的L-精氨酸和吡哆胺通过促进血管生成和抑制晚期糖基化终末产物改善伤口微环境。感染发生后,这种重塑的微环境增强中性粒细胞的募集和抗菌能力,使糖尿病伤口重新获得形成早期炎症区并迅速清除入侵细菌的能力。此外,抗菌免疫产生的过量ROS会降解中性粒细胞靶向聚合物,释放NLRP3抑制剂,从而抑制炎症小体过度活化并加速中性粒细胞凋亡,进而促进巨噬细胞胞葬作用以启动组织修复。我们追踪了HHD塑造的中性粒细胞,并证实其在预防感染和加速伤口愈合方面的功效。总之,HHD是治疗中性粒细胞依赖性糖尿病伤口的一种有前景的平台。意义声明:中性粒细胞功能障碍是导致糖尿病伤口感染和愈合受损的关键因素。全面调控中性粒细胞命运仍面临重大挑战。在本研究中,我们构建了一种免疫调节复合水凝胶以调控糖尿病伤口中的中性粒细胞命运:1)改善伤口微环境,增强中性粒细胞募集并强化其抗菌活性;2)通过中性粒细胞靶向聚合物诱导中性粒细胞凋亡;3)通过凋亡中性粒细胞促进巨噬细胞胞葬作用和表型转换,从而加快组织修复。

3肿瘤护理 (3篇)

临床研究 (3篇)

Endoscopy IF 11.8 2026-10-07 PMID: 42843632
BACKGROUND : In Sweden, a nationwide colorectal cancer (CRC) screening program for individuals aged 60-74 started in 2021; to meet the increasing demand for colonoscopy, nurse endoscopists may play a key role - provided they maintain high technical quality. This observational study aimed to evaluate the nurse endoscopists' performance in the screening program, focusing on core quality indicators. METHODS : Data were extracted from the Swedish Quality Register for Colonoscopies and Colorectal Cancer Screening (SveReKKS), including all screening colonoscopies performed between 1 April 2019 and 31 August 2025. Key quality indicators - adenoma detection rate (ADR), cecal and ileal intubation rates, bowel preparation, sedation use, and complications - were compared between nurse and physician endoscopists using generalized linear mixed-effects models with a logit link. RESULTS : Of 27 978 colonoscopies, 42 % were performed by nurses. Nurses had a higher ADR (57 % vs. 46 %; odds ratio [OR] 1.55, 95 %CI 1.47-1.62), and 3.6 % of the nurses had an ADR < 25 %, compared with 11.2 % of the physicians. Nurses also had higher odds of ileal intubation (OR 1.2, 95 %CI 1.1-1.2) and longer withdrawal times. CONCLUSIONS : Nurse endoscopists demonstrated high quality colonoscopy performance in CRC screening and represent a valuable resource to meet increasing service demands without compromising clinical standards.
中文摘要:背景:瑞典于2021年启动了针对60-74岁人群的全国性结直肠癌筛查项目;为满足不断增加的结肠镜检查需求,护士内镜医师可能发挥关键作用——前提是他们保持高技术质量。本观察性研究旨在评估护士内镜医师在筛查项目中的表现,重点关注核心质量指标。方法:数据提取自瑞典结肠镜检查与结直肠癌筛查质量登记(SveReKKS),纳入2019年4月1日至2025年8月31日期间进行的所有筛查性结肠镜检查。采用带logit链接的广义线性混合效应模型,比较护士与医生内镜医师在关键质量指标上的差异,包括腺瘤检出率(ADR)、盲肠和回肠插管率、肠道准备、镇静使用及并发症。结果:在27978例结肠镜检查中,42%由护士完成。护士的ADR更高(57% vs. 46%;比值比[OR] 1.55,95%CI 1.47-1.62),并且护士中ADR<25%的比例为3.6%,而医生为11.2%。护士回肠插管的优势比也更高(OR 1.2,95%CI 1.1-1.2),退镜时间更长。结论:护士内镜医师在结直肠癌筛查中表现出高质量的结肠镜检查水平,是在不降低临床标准的前提下满足日益增长的服务需求的重要资源。
Gut IF 24.6 2026-10-07 PMID: 41748160
In the past 5 years, clinical trials on immune checkpoint inhibitors (ICIs) for the treatment of locally advanced rectal cancer (LARC) have flourished globally, and China has become one of the leading regions in this field. In response to the breakthrough progress and accumulation of evidence from key clinical trials, the Chinese Society of Colorectal Surgery has recognised the need for updated consensus guidance on the development of perioperative and organ-preserving treatment strategies for LARC. This expert consensus guidance provided unified standards for the indications, medication regimens, efficacy evaluations and follow-up of ICIs in this population, with a focus mainly on perioperative management and organ-sparing strategies. The diagnostic part of this consensus guidance is based on the internationally recognised definition of mismatch repair/microsatellite instability detection and emphasises the importance of multidisciplinary teams in treatment decision-making. In terms of treatment, based on the results of key trials that have changed clinical practice in the past 5 years, this expert consensus provides graded recommendations for the duration of preoperative immunotherapy and the necessity of postoperative adjuvant therapy, local resection and organ preservation strategies. Moreover, we refined the management process for the safety of perioperative immunotherapy. This document aims to provide a reference for surgeons; internal medicine, radiation therapy, pathology and imaging physicians; patients and nursing staff involved in the treatment of LARC, as well as health policy makers.
中文摘要:过去5年,免疫检查点抑制剂(ICIs)治疗局部晚期直肠癌(LARC)的临床试验在全球蓬勃开展,中国已成为该领域领先地区之一。针对关键临床试验的突破性进展和证据积累,中华结直肠外科学会认识到需要更新关于LARC围手术期和器官保留治疗策略制定的共识指导。本专家共识指导为ICIs在该人群中的适应证、用药方案、疗效评估和随访提供了统一标准,主要关注围手术期管理和器官保留策略。本共识指导的诊断部分基于国际公认的错配修复/微卫星不稳定性检测定义,并强调多学科团队在治疗决策中的重要性。在治疗方面,基于过去5年改变临床实践的关键试验结果,本专家共识对术前免疫治疗持续时间以及术后辅助治疗、局部切除和器官保留策略的必要性提供了分级推荐。此外,我们细化了围手术期免疫治疗安全性的管理流程。本文旨在为外科医生、内科、放疗、病理和影像科医生、参与LARC治疗的患者和护理人员以及卫生政策制定者提供参考。
British journal of anaesthesia IF 10.3 2026-10 PMID: 42618366
Ketamine is commonly used perioperatively as an anaesthetic and analgesic adjunct and has demonstrated potential antitumour effects in preclinical studies. However, clinical and epidemiological data on its association with long-term outcomes after oncologic surgery remain limited. We conducted a retrospective cohort study using the TriNetX US Collaborative Network, including adults (≥18 yr) undergoing major solid tumour cancer surgery between January 1, 2014, and April 1, 2023. The primary exposure was ketamine administration on the day of surgery. Propensity score matching (1:1) was performed using patient characteristics, comorbidities, oncologic diagnoses, and surgery type. The primary outcome was 3-yr mortality, and the secondary outcome was 5-yr mortality. Among 176 149 eligible patients, 29 547 matched pairs were analysed. Perioperative ketamine administration was not associated with lower 3-yr mortality (16.7% vs 16.0%; hazard ratio [HR], 1.04; 95% confidence interval [CI], 1.00-1.09; q=0.187). There was no difference in 5-yr mortality. Across sensitivity and subgroup analyses by cancer type and perioperative exposures, ketamine was not associated with improved survival after adjustment for multiple comparisons. In an exploratory analysis, ketamine exposure was associated with a lower risk of a composite of surrogate markers suggestive of cancer progression or advanced disease, including initiation of chemotherapy, radiotherapy, or palliative care ≥6 months after surgery (HR, 0.82; 95% CI, 0.74-0.92; q=0.013). In this research network study, perioperative ketamine use was not associated with reduced mortality after major cancer surgery. This finding aligns with previous large-scale studies showing no long-term survival benefit for specific anaesthetic agents in oncologic surgery.
中文摘要:氯胺酮在围手术期常作为麻醉与镇痛的辅助用药,且临床前研究显示其具有潜在的抗肿瘤作用。然而,关于其与肿瘤手术后长期结局相关性的临床与流行病学数据仍有限。我们利用TriNetX美国协作网络开展了一项回顾性队列研究,纳入2014年1月1日至2023年4月1日期间接受实体瘤大手术的成人(≥18岁)。主要暴露为手术当日使用氯胺酮。采用倾向性评分1:1匹配,匹配变量包括患者特征、合并症、肿瘤诊断和手术类型。主要结局为3年死亡率,次要结局为5年死亡率。在176149例符合条件的患者中,共分析29547对匹配病例。围手术期使用氯胺酮与更低的3年死亡率无关(16.7% 对 16.0%;风险比[HR]为1.04;95%置信区间[CI]为1.00-1.09;q=0.187)。5年死亡率亦无差异。在按肿瘤类型和围手术期暴露进行的敏感性分析及亚组分析中,经多重比较校正后,氯胺酮与生存改善均无关联。在一项探索性分析中,氯胺酮暴露与提示肿瘤进展或疾病晚期的替代指标复合终点风险降低相关,该复合终点包括术后≥6个月开始化疗、放疗或姑息治疗(HR为0.82;95% CI为0.74-0.92;q=0.013)。在这项研究网络研究中,围手术期使用氯胺酮与肿瘤大手术后死亡率降低无关。该发现与既往大规模研究一致,即特定麻醉药物在肿瘤手术中并无长期生存获益。

4手术室护理 (2篇)

临床研究 (2篇)

British journal of anaesthesia IF 10.3 2026-10 PMID: 42744462
The WHO VigiBase is a worldwide registry of cardiac arrests associated with anaesthesia cases. Using data from VigiBase, Perez and Fettiplace established a Risk of Reporting (RoR) metric for each common anaesthetic agent, comparing the occurrence of cardiac arrest associated with a given agent relative to its reported use in the database with propofol as the reference agent. This 'RoR' metric can inform future research into the association between specific anaesthesia medications and the risk for perioperative cardiac arrest.
中文摘要:世界卫生组织 VigiBase 是一个全球性的麻醉相关心脏骤停病例登记数据库。Perez 和 Fettiplace 利用 VigiBase 的数据,为每种常用麻醉药物建立了一个报告比值比(RoR)指标,以丙泊酚为参照药物,比较特定药物相关心脏骤停的发生情况与其在数据库中报告使用的比例。这一「RoR」指标可为未来研究特定麻醉药物与围术期心脏骤停风险之间的关联提供信息。
British journal of anaesthesia IF 10.3 2026-10 PMID: 42744460
Preoperative liquid fasting durations remain unacceptably long worldwide and represent one of the most common yet under-recognised sources of avoidable perioperative harm. Recent international multidisciplinary consensus has emphasised the need for institutional implementation strategies that recommend, where appropriate, more liberal clear liquid protocols to minimise prolonged fasting. Meaningful improvement therefore requires active implementation through routine measurement and audit of actual fasting durations relative to society recommendations, institutional accountability, and quality improvement initiatives that bridge the evidence-practice gap. Failure to implement strategies that prevent known harm is not a passive omission but an active decision, and addressing prolonged fasting is fundamental to delivering patient-centred perioperative care, improving the patient experience, and enhancing quality of recovery. Reducing prolonged perioperative fasting is a patient safety priority, not simply a guideline recommendation.
中文摘要:术前液体禁食时长在全球范围内仍不必要地过长,是可避免的围手术期伤害中最常见却最易被忽视的来源之一。近期国际多学科共识强调,需要机构层面的实施策略,在适当情况下推荐更宽松的清流质方案,以尽量减少长时间禁食。因此,有意义的改善需要通过常规测量和审核实际禁食时长与社会建议之间的差距、机构问责,以及弥合证据-实践差距的质量改进举措来积极实施。未能实施防止已知伤害的策略并非被动遗漏,而是一种主动决定;解决长时间禁食问题对于提供以患者为中心的围手术期照护、改善患者体验和提高康复质量至关重要。减少围手术期长时间禁食是患者安全优先事项,而不仅仅是一条指南建议。

5慢病管理 (1篇)

临床研究 (1篇)

European heart journal IF 45.3 2026-10-07 PMID: 42843319
Heat extremes significantly increase morbidity and mortality, particularly among older adults and people with cardiovascular disease (CVD). The year 2024 was the warmest year on record and the first calendar year in which the annual global mean temperature exceeded 1.5°C above pre-industrial levels-exposing people with CVD to a record number of extreme heat days. With the frequency and intensity of heat extremes expected to rise, the health risks for people with CVD will continue to escalate. There is an urgent need to provide scientific evidence to advise patients and healthcare professionals to manage cardiovascular health under these circumstances. This statement builds on a prior European Society of Cardiology document that explored the pathophysiological mechanisms underlying increased risk of cardiovascular events during heat extremes. Here, evidence informed advice guided by experts in thermal physiology and CVD is provided for clinicians and healthcare professionals to help advise their patients and reduce the negative impacts of heat on CVD health. The advice, while novel, relates to best practice for multidisciplinary care before, during, and after heat extremes, ensuring a proactive and comprehensive approach to patient safety. By integrating current evidence with practical strategies, this statement aims to bridge the evidence-to-practice gap and enhance preparedness for the increasing burden of climate-change driven health risks.
中文摘要:极端高温显著增加发病率和死亡率,尤其是在老年人和心血管疾病(CVD)患者中。2024年是有记录以来最热的一年,也是首个全球年平均气温较工业化前水平高出1.5°C以上的日历年,使CVD患者暴露于创纪录数量的极端高温日。随着极端高温的频率和强度预计将上升,CVD患者的健康风险将持续加剧。迫切需要提供科学证据,以指导患者和医疗保健专业人员在这种情况下管理心血管健康。本声明基于欧洲心脏病学会先前的一份文件,该文件探讨了极端高温期间心血管事件风险增加的病理生理机制。在此,由热生理学和CVD专家指导的循证建议被提供给临床医生和医疗保健专业人员,以帮助其指导患者并减少高温对CVD健康的不利影响。这些建议虽然新颖,但涉及极端高温前、中、后的多学科护理最佳实践,确保对患者安全采取主动且全面的方法。通过将当前证据与实用策略相结合,本声明旨在弥合证据到实践的差距,并增强对气候变化驱动的健康风险日益加重负担的准备。

6护理教育/管理 (1篇)

临床研究 (1篇)

JMIR medical education IF 13.9 2026-10-05 PMID: 42832760
The undergraduate stage is critical for developing nursing students' disaster nursing competencies; however, traditional lecture-based teaching often fails to promote active learning, and innovative instructional models remain underused in this field. The BOPPPS (Bridge-in, Objective, Preassessment, Participatory Learning, Postassessment, and Summary) model is a student-centered, closed-loop instructional framework that emphasizes active participatory learning and real-time feedback. This study aimed to evaluate the effects of a BOPPPS-based blended teaching model on disaster nursing competencies and academic outcomes among undergraduate nursing students. This study used a quasi-experimental design with 77 undergraduate nursing students allocated to 3 groups: an experimental group receiving BOPPPS-based blended teaching (n=27), a control group with traditional lecture-based teaching (n=25), and a comparison group without systematic instruction (n=25). Questionnaires were used to assess students' self-perceived disaster nursing knowledge, professional operational skills, and overall comprehensive competencies. The final examination assessed students' mastery of theoretical knowledge and applied reasoning. All 3 groups showed significant within-group improvements in disaster competence (all P<.001, n=77). Intergroup comparisons revealed significant differences (H=8.843, P=.01, η²=0.093); post hoc analysis showed that the experimental group (mean rank=48.79) scored significantly higher than the comparison group (mean rank=29.76, Padj=.009), but not significantly higher than the control group (mean rank=38.32, Padj=.34). The experimental group had a significantly higher overall course score than the control group (86.93, SD 5.08 vs 81.60, SD 6.90; t50=-3.186, P=.002). The implementation of a disaster nursing curriculum positively impacts students' disaster nursing competency. Since the BOPPPS-based blended teaching model promotes active student engagement and improves teaching quality, we recommend its integration into disaster nursing education.
中文摘要:本科阶段是培养护生灾害护理能力的关键时期;然而,传统以讲授为主的教学往往难以促进主动学习,创新性教学模式在该领域的应用仍然不足。BOPPPS(导入、目标、前测、参与式学习、后测和总结)模式是一种以学生为中心、闭环式的教学框架,强调主动参与式学习和实时反馈。本研究旨在评价基于BOPPPS的混合式教学模式对本科护生灾害护理能力和学业成绩的影响。本研究采用类实验设计,将77名本科护生分为3组:接受基于BOPPPS混合式教学的实验组(n=27)、接受传统讲授式教学的对照组(n=25),以及未接受系统教学的比较组(n=25)。采用问卷评估护生自我感知的灾害护理知识、专业操作技能和综合能力。期末考试评估护生对理论知识的掌握和应用推理能力。3组学生的灾害护理能力在组内均有显著提高(均P<.001,n=77)。组间比较显示存在显著差异(H=8.843,P=.01,η²=0.093);事后分析表明,实验组(平均秩48.79)得分显著高于比较组(平均秩29.76,Padj=.009),但未显著高于对照组(平均秩38.32,Padj=.34)。实验组的课程总成绩显著高于对照组(86.93,SD 5.08 对 81.60,SD 6.90;t50=-3.186,P=.002)。实施灾害护理课程对护生的灾害护理能力具有积极影响。由于基于BOPPPS的混合式教学模式能够促进学生主动参与并提高教学质量,我们建议将其纳入灾害护理教育。

7康复护理 (1篇)

基础研究 (1篇)

Acta biomaterialia IF 10.4 2026-10-02 PMID: 42826786
Neurological injuries remain difficult to treat due to the complex microenvironment and the limited intrinsic regenerative capacity of neural tissues. Recently, wireless neuromodulation based on piezoelectric nanomaterials, particularly barium titanate (BaTiO3), has emerged as a promising alternative to conventional implantable electrical stimulation. Polar BaTiO3 ceramics generally have higher piezoelectric charge coefficients than conventional Polyvinylidene Fluoride (PVDF) and Poly(vinylidene fluoride-co-trifluoroethylene) (P(VDF-TrFE)) films, are more resistant to degradation than ZnO, and are lead-free unlike Lead Zirconate Titanate (PZT), although their rigidity and potential persistence in tissue complicate soft-tissue integration and post-treatment clearance. This review systematically summarizes recent advances in BaTiO3-enabled piezoelectric neuromodulation and further outline preclinical applications in pain management and metabolic regulation across multiple neurological disorders, including traumatic brain injury (TBI), spinal cord injury (SCI), peripheral nerve injury (PNI), and post-traumatic epilepsy (PTE). We subsequently analyze the underlying mechanisms for neural repair, highlighting modulation of voltage-gated ion channels (e.g., Ca2+ and Na+) to regulate neuronal excitability and stem cell differentiation, mitochondrial targeting to influence metabolism and immune polarization, and controlled intracellular ion release (e.g., Zn2+) to modulate gene transcription. To enhance electromechanical-biological coupling in vivo, interface engineering strategies for BaTiO3 are also discussed, with emphasis on surface modification approaches such as polydopamine functionalization and integration with conductive hydrogels to improve biomechanical compatibility. Finally, key challenges for clinical translation, including the lack of standardized stimulation parameters, are addressed, providing insights for the development of next-generation neuromodulation-based therapies. STATEMENT OF SIGNIFICANCE: Neurological injuries and diseases represent some of the most formidable clinical challenges because neural tissues have limited regenerative capacity, whereas conventional wired electrical stimulation is invasive. Although BaTiO3-based piezoelectric nanomaterials have emerged as important wireless transducers for neuromodulation, the field still lacks a systematic framework linking the fundamental electromechanical properties of BaTiO3 to disease-relevant therapeutic mechanisms and barriers to clinical translation. This review provides a systematic, mechanism-oriented assessment of BaTiO3-based wireless neuromodulation by outlining its crystallographic basis and multiscale structural engineering and examining how localized electrical potentials may modulate voltage-gated ion channels, the neuroimmune microenvironment, and stem-cell metabolism. Ultimately, we critically analyze the prominent bottlenecks impeding preclinical-to-clinical translation, involving long-term biosafety, biomechanical compatibility, manufacturing reproducibility, etc.
中文摘要:由于复杂的微环境和神经组织有限的固有再生能力,神经系统损伤仍然难以治疗。近年来,基于压电纳米材料尤其是钛酸钡(BaTiO3)的无线神经调控,已成为传统植入式电刺激的一种有前景的替代方案。极性BaTiO3陶瓷通常比传统聚偏氟乙烯(PVDF)和聚(偏氟乙烯-三氟乙烯)(P(VDF-TrFE))薄膜具有更高的压电电荷系数,比ZnO更耐降解,并且不同于锆钛酸铅(PZT)而具有无铅特性,尽管其刚性和在组织中的潜在持久性使软组织整合与治疗后清除复杂化。本综述系统总结了BaTiO3驱动压电神经调控的最新进展,并进一步概述其在多种神经系统疾病中用于疼痛管理和代谢调节的临床前应用,这些疾病包括创伤性脑损伤(TBI)、脊髓损伤(SCI)、周围神经损伤(PNI)和创伤后癫痫(PTE)。我们随后分析了神经修复的潜在机制,重点包括调节电压门控离子通道(如Ca2+和Na+)以调控神经元兴奋性和干细胞分化、靶向线粒体以影响代谢和免疫极化,以及控制细胞内离子释放(如Zn2+)以调节基因转录。为增强体内机电-生物耦合,本文还讨论了BaTiO3的界面工程策略,重点强调表面修饰方法,如聚多巴胺功能化以及与导电水凝胶整合以改善生物力学相容性。最后,阐述了临床转化的关键挑战,包括缺乏标准化刺激参数,为开发下一代基于神经调控的疗法提供见解。意义声明:由于神经组织再生能力有限,而传统有线电刺激具有侵入性,神经系统损伤和疾病是最严峻的临床挑战之一。尽管基于BaTiO3的压电纳米材料已成为神经调控的重要无线换能器,但该领域仍缺乏将BaTiO3的基本机电特性与疾病相关治疗机制及临床转化障碍联系起来的系统框架。本综述通过概述其晶体学基础和多尺度结构工程,并审视局部电势如何调节电压门控离子通道、神经免疫微环境和干细胞代谢,对基于BaTiO3的无线神经调控进行了系统、以机制为导向的评估。最终,我们批判性分析了阻碍临床前向临床转化的突出瓶颈,涉及长期生物安全性、生物力学相容性、制造可重复性等。

8感染控制 (1篇)

临床研究 (1篇)

JAMA network open IF 11.7 2026-10-01 PMID: 42837154
Catheter-associated urinary tract infection (CAUTI) remains a common and morbid health care-associated infection. Although evidence-based prevention strategies are well established, the degree to which hospitals adopt and sustain these practices over time and whether trajectories differ between Department of Veterans Affairs (VA) and nonfederal systems are not well described. To examine 20-year trends in reported CAUTI prevention practices in US hospitals and compare practice use between VA and nonfederal hospitals. This survey study used repeated cross-sectional national surveys conducted every 4 years from 2005 to 2025. Surveys were sent to the lead infection preventionist at all VA hospitals, as well as a random sample of nonfederal, general medical, and surgical US hospitals with intensive care units. Data were analyzed from January to August 2026. The outcome of interest was regular use of specific CAUTI prevention practices, including urinary catheter reminders or stop orders, nurse-initiated discontinuation, bladder ultrasonography, intermittent catheterization, external catheters, aseptic insertion, surveillance systems, and leadership prioritization of CAUTI prevention. Over the 20 year period, 1461 unique hospitals participated in at least 1 study survey, with mean (SD) response rates for the 6 survey waves of 63.4% (8.4%) for VA hospitals and 56.5% (9.2%) for nonfederal hospitals. Both VA and nonfederal hospitals demonstrated substantial long-term increases in surveillance infrastructure, routine monitoring of catheter duration, and leadership prioritization of CAUTI prevention. In nonfederal hospitals, regular use of urinary catheter reminders or stop orders increased from 34 of 372 hospitals (9.1%) in 2005 to 149 of 306 hospitals (48.7%) in 2025, and nurse-initiated discontinuation increased from 43 of 379 hospitals (11.3%) in 2009 to 179 of 307 hospitals (58.3%) in 2025. VA hospitals also showed significant increases in these practices over time, although use in 2025 was lower than nonfederal hospitals (urinary catheter reminders or stop orders: 10 of 90 hospitals [11.1%] in 2005 and 23 of 73 hospitals [31.5%] in 2025; nurse-initiated discontinuation: 10 of 69 hospitals (14.5%) in 2009 and 28 of 74 hospitals [37.8%] in 2025). Use of silver alloy Foley catheters declined markedly in nonfederal hospitals (from 126 of 389 hospitals [32.4%] in 2005 to 41 of 294 hospitals [14.0%] in 2025) but remained stable in VA facilities. External catheter use increased substantially, particularly in women, with 194 of 310 nonfederal hospitals (62.6%) and 30 of 73 VA hospitals (41.1%) reporting regular use by 2025. Nearly universal use of CAUTI surveillance systems was observed in both settings (309 of 315 nonfederal hospitals [98.1%] and 73 of 74 VA hospitals [98.7%]). This survey study of infection-prevention practice use found that US hospitals substantially expanded use of many CAUTI prevention practices, particularly surveillance and monitoring systems, over the past 20 years. However, variability in use of high-yield practices, such as reminders and nurse-driven discontinuation, persisted, underscoring the need for sustained, system-level strategies to optimize urinary catheter safety across health care settings.
中文摘要:导管相关尿路感染(CAUTI)仍是一种常见且致病的医疗保健相关感染。尽管循证预防策略已较为完善,但医院在多大程度上采用并长期维持这些实践,以及退伍军人事务部(VA)系统与非联邦系统之间的变化轨迹是否存在差异,目前尚缺乏充分描述。本研究旨在考察美国医院报告的CAUTI预防实践的20年趋势,并比较VA医院与非联邦医院之间的实践使用情况。本调查研究使用2005年至2025年每4年开展一次的重复横断面全国调查。调查发送至所有VA医院的感染预防负责人,以及随机抽取的设有重症监护病房的非联邦综合内科与外科美国医院。数据分析时间为2026年1月至8月。关注的结局为特定CAUTI预防实践的常规使用情况,包括导尿管提醒或停止医嘱、护士发起的拔管、膀胱超声检查、间歇导尿、外置导尿管、无菌插入、监测系统以及领导层对CAUTI预防的优先重视。在20年期间,共有1461家唯一医院参与了至少1次研究调查;6轮调查中,VA医院的平均(SD)应答率为63.4%(8.4%),非联邦医院为56.5%(9.2%)。VA医院和非联邦医院在监测基础设施、导尿管留置时间的常规监测以及领导层对CAUTI预防的优先重视方面均表现出显著的长期增长。在非联邦医院中,导尿管提醒或停止医嘱的常规使用从2005年的372家医院中的34家(9.1%)增至2025年的306家医院中的149家(48.7%),护士发起的拔管从2009年的379家医院中的43家(11.3%)增至2025年的307家医院中的179家(58.3%)。VA医院在这些实践方面也随时间显著增加,尽管2025年的使用率低于非联邦医院(导尿管提醒或停止医嘱:2005年为90家医院中的10家[11.1%],2025年为73家医院中的23家[31.5%];护士发起的拔管:2009年为69家医院中的10家(14.5%),2025年为74家医院中的28家(37.8%)。银合金Foley导尿管的使用在非联邦医院中明显下降(从2005年的389家医院中的126家[32.4%]降至2025年的294家医院中的41家[14.0%]),但在VA机构中保持稳定。外置导尿管的使用大幅增加,尤其是在女性中;到2025年,310家非联邦医院中有194家(62.6%)和73家VA医院中有30家(41.1%)报告常规使用。两种机构中均观察到CAUTI监测系统接近普遍使用(315家非联邦医院中的309家[98.1%]和74家VA医院中的73家[98.7%])。这项关于感染预防实践使用情况的调查研究发现,在过去20年中,美国医院大幅扩大了多种CAUTI预防实践的使用,尤其是监测和监控系统。然而,高收益实践(如提醒和护士驱动的拔管)的使用仍存在差异,这凸显出需要持续的系统层面策略,以优化各类医疗环境中的导尿管安全。

9老年护理 (1篇)

临床研究 (1篇)

JAMA network open IF 11.7 2026-10-01 PMID: 42832198
Long-term nursing home residents with atrial fibrillation (AF) and activities of daily living (ADL) disability are at high risk of bleeding and death, making the net benefit of anticoagulation uncertain. To compare the association of oral anticoagulant (OAC) use vs nonuse with ischemic stroke and major bleeding in long-term nursing home residents with AF and ADL disability. This cohort study used US Medicare claims linked with the Minimum Data Set (January 1, 2013, to December 31, 2022). Nursing home residents with nonvalvular AF and impairment in 3 or more ADLs were included. Three cohorts comparing use of apixaban, rivaroxaban, or warfarin with nonuse were constructed using incidence-density sampling. Initiation of apixaban, rivaroxaban, or warfarin use. Primary outcomes were ischemic stroke, major bleeding, and their composite. Propensity score (PS) matching balanced 111 covariates. Adjusted rate ratios (ARRs) with 95% CIs were estimated. Tipping-point analyses assessed the relative weighting ischemic stroke vs major bleeding required to favor anticoagulation. Direct active-comparator analyses compared apixaban with rivaroxaban and warfarin. The study comprised 26 940 nursing home residents (median [IQR] age, 82 [74,88] years; 17 504 [65.0%] female), including PS-matched cohorts of 7600 residents receiving apixaban, 2654 receiving rivaroxaban, and 3216 receiving warfarin. Compared with nonuse, use of all OACs was associated with lower rates of ischemic stroke (apixaban: ARR, 0.53; 95% CI, 0.38-0.73; rivaroxaban: ARR, 0.48; 95% CI, 0.27-0.87; warfarin: ARR, 0.47; 95% CI, 0.25-0.88) and higher rates of major bleeding (apixaban: ARR, 1.62; 95% CI, 1.29-2.03; rivaroxaban: ARR, 2.68; 95% CI, 1.84-3.93; warfarin: ARR, 3.02; 95% CI, 2.15-4.25). Only apixaban was not associated with a higher composite outcome (ARR, 1.08; 95% CI, 0.90-1.30), whereas rivaroxaban (ARR, 1.62; 95% CI, 1.20-2.18) and warfarin (ARR, 1.99; 95% CI, 1.50-2.63) were associated with higher rates. Findings were consistent across frailty strata, although stroke reduction with apixaban was attenuated among frail individuals. Tipping-point analyses indicated a more favorable benefit-risk balance for apixaban than for rivaroxaban or warfarin. Among nursing home residents with AF and ADL disability, OAC use was associated with lower ischemic stroke but higher major bleeding rates than nonuse. Apixaban demonstrated the most favorable benefit-risk profile among the OACs evaluated. These findings may inform individualized anticoagulation decisions.
中文摘要:长期居住在养老院的心房颤动(AF)合并日常生活活动能力(ADL)残疾居民具有较高的出血和死亡风险,因此抗凝治疗的净获益尚不确定。旨在比较长期居住在养老院且合并AF和ADL残疾的居民中,口服抗凝药(OAC)使用与未使用和缺血性卒中及大出血的相关性。本队列研究使用美国Medicare理赔数据与最小数据集(Minimum Data Set)链接(2013年1月1日至2022年12月31日)。纳入非瓣膜性AF且存在3项或以上ADL受损的养老院居民。采用发病密度抽样构建了3个队列,分别比较阿哌沙班、利伐沙班或华法林使用与未使用。暴露为开始使用阿哌沙班、利伐沙班或华法林。主要结局为缺血性卒中、大出血及其复合结局。倾向性评分(PS)匹配平衡了111个协变量。估计了校正率比(ARR)及其95%CI。Tipping-point分析评估了为支持抗凝治疗,缺血性卒中相对于大出血所需的相对权重。直接活性对照分析比较了阿哌沙班与利伐沙班和华法林。研究共纳入26 940名养老院居民(中位[IQR]年龄,82[74,88]岁;17 504[65.0%]为女性),包括PS匹配队列:7600名接受阿哌沙班、2654名接受利伐沙班和3216名接受华法林的居民。与未使用相比,所有OAC的使用与较低的缺血性卒中发生率相关(阿哌沙班:ARR,0.53;95%CI,0.38-0.73;利伐沙班:ARR,0.48;95%CI,0.27-0.87;华法林:ARR,0.47;95%CI,0.25-0.88),并与较高的大出血发生率相关(阿哌沙班:ARR,1.62;95%CI,1.29-2.03;利伐沙班:ARR,2.68;95%CI,1.84-3.93;华法林:ARR,3.02;95%CI,2.15-4.25)。只有阿哌沙班与复合结局升高无关(ARR,1.08;95%CI,0.90-1.30),而利伐沙班(ARR,1.62;95%CI,1.20-2.18)和华法林(ARR,1.99;95%CI,1.50-2.63)与较高的发生率相关。各衰弱分层中的结果一致,尽管阿哌沙班降低卒中的效应在衰弱个体中有所减弱。Tipping-point分析表明,阿哌沙班较利伐沙班或华法林具有更有利的获益-风险平衡。在合并AF和ADL残疾的养老院居民中,与未使用相比,OAC使用与较低的缺血性卒中发生率但较高的大出血发生率相关。在评估的OAC中,阿哌沙班表现出最有利的获益-风险特征。这些发现可能为个体化抗凝决策提供依据。

10移动健康/远程护理 (1篇)

临床研究 (1篇)

JAMA network open IF 11.7 2026-10-01 PMID: 42826022
For long-term residents of skilled nursing facilities (SNFs), greater use of telemedicine for specialist care may improve access to and overall quality of care. Although policy changes during the COVID-19 pandemic facilitated greater use of telemedicine, such use now is rare, and it is unclear why. To examine SNF clinical leaders' perceptions of telemedicine use and explanations of lower use among long-term residents. This survey study was conducted online and via postal mail from February 7 to July 28, 2025, among directors of nursing of SNFs, the central decision-makers for daily clinical operations. A probability-based sample was drawn from a listing of all 14 084 SNFs in the US, stratified to ensure reach to facilities of different sizes and varying telemedicine utilization. This study measured the perceptions of key factors associated with quality of care in SNFs. Telemedicine use for specialist care and reasons for telemedicine use and disuse were solicited from SNFs' directors of nursing. The demographic characteristics of SNFs surveyed were weighted to Centers for Medicare & Medicaid Services benchmarks to reflect the profile of SNFs nationally. Among 1001 directors of nursing sent invitation letters, 379 (39%) participated in this study. Most directors of nursing whose residents used telemedicine confirmed its proposed advantages: respondents said a top reason for using telemedicine is that it helped less-mobile patients get appointments (77%; 95% CI, 71%-82%) and that it helped improve patients' quality of care (73%; 95% CI, 67%-78%). Top reasons for not using telemedicine among less-frequent users and nonusers were: telemedicine visits were not frequently offered by specialists (73%; 95% CI, 67%-79%) and telemedicine did not offer higher quality of care over normal practices (62%; 95% CI, 56%-68%). A majority of directors of nursing who use telemedicine (60%; 95% CI, 54%-65%) also reported that telemedicine placed additional time burdens on nursing staff. This survey study found that frontline clinical leaders view specialist telemedicine care as a useful tool for SNFs, particularly for patients with low mobility. However, they reported that telemedicine is offered too infrequently by specialists and adds to nurses' schedules. Policy and payment reforms should include incentives for specialists to offer telemedicine and reimbursement for nursing staff time.
中文摘要:对于熟练护理机构(SNFs)的长期住民而言,更多使用远程医疗进行专科诊疗可能改善其获得医疗服务和整体照护质量。尽管COVID-19大流行期间的政策变化促进了远程医疗的更广泛使用,但此类使用目前很少,原因尚不清楚。旨在考察SNF临床领导者对远程医疗使用的看法,以及对长期住民中使用率较低的解释。这项调查研究于2025年2月7日至7月28日通过在线和邮寄方式进行,对象为SNF的护理主任,他们是日常临床运营的核心决策者。研究从美国全部14 084家SNF的名单中抽取了一个基于概率的样本,并进行分层以确保覆盖不同规模和不同远程医疗使用情况的机构。本研究测量了对SNF照护质量相关关键因素的看法。研究向SNF的护理主任征集了专科诊疗远程医疗使用情况,以及使用和不使用远程医疗的原因。所调查SNF的人口学特征根据美国医疗保险和医疗补助服务中心的基准进行加权,以反映全国SNF的概况。在1001名收到邀请信的护理主任中,379名(39%)参与了本研究。大多数其住民使用远程医疗的护理主任证实了其预期优势:受访者表示,使用远程医疗的首要原因是它帮助行动不便的患者获得预约(77%;95% CI,71%-82%),并且有助于改善患者的照护质量(73%;95% CI,67%-78%)。在较少使用者和非使用者中,不使用远程医疗的首要原因是:专科医生不经常提供远程医疗就诊(73%;95% CI,67%-79%),以及远程医疗并未比常规做法提供更高质量的照护(62%;95% CI,56%-68%)。使用远程医疗的大多数护理主任(60%;95% CI,54%-65%)还报告称,远程医疗给护理人员带来了额外的时间负担。这项调查研究发现,一线临床领导者认为专科远程医疗是SNF的有用工具,尤其对行动能力低下的患者。然而,他们报告称专科医生提供远程医疗的频率过低,并且增加了护士的日程负担。政策和支付改革应包含激励专科医生提供远程医疗,以及对护理人员时间进行补偿。

11患者安全 (1篇)

临床研究 (1篇)

Circulation IF 41.3 2026-10-01 PMID: 42817881
Antithrombotic therapy undertreatment includes omission, nonadherence, underdosing, and clinical circumstances that result in subtherapeutic antithrombotic levels. Antithrombotic undertreatment has profound implications for patient safety, public health, and healthcare costs. Due to deviation from evidence-based clinical practice, misperceptions of bleeding versus thrombotic risk, and inequities in healthcare access, many patients with atrial fibrillation, venous thromboembolism, or peripheral artery disease remain untreated or receive suboptimal anticoagulant dosing. Antithrombotic undertreatment has been shown to increase rates of ischemic stroke, systemic embolism, recurrent thrombosis, and mortality. Real-world data continue to highlight substantial gaps in care, which appear to be magnified in patients with inequity in social determinants of health. The emergence of antithrombotic stewardship, in concert with growing bodies of literature on antithrombotic agent underdosing, represents a transformative opportunity to address these gaps through structured, interprofessional, and evidence-based approaches. Through interdisciplinary collaboration, healthcare professionals are well positioned to enhance patient health and safety by recognizing and recommitting to reducing antithrombotic undertreatment.
中文摘要:抗血栓治疗不足包括遗漏、不依从、剂量不足以及导致抗血栓水平低于治疗水平的临床情况。抗血栓治疗不足对患者安全、公共卫生和医疗费用具有深远影响。由于偏离循证临床实践、对出血与血栓风险的错误认识以及医疗可及性方面的不平等,许多房颤、静脉血栓栓塞或外周动脉疾病患者仍未接受治疗或接受次优抗凝剂量。抗血栓治疗不足已被证明会增加缺血性卒中、系统性栓塞、复发性血栓形成和死亡率。真实世界数据持续凸显出医疗照护中的巨大差距,而这些差距在健康社会决定因素方面存在不平等的患者中似乎被放大。抗血栓药物管理的出现,连同关于抗血栓药物剂量不足的文献日益增多,为通过结构化、跨专业和循证的方法解决这些差距提供了一个变革性机会。通过跨学科合作,医疗保健专业人员处于有利位置,可以通过识别并再次承诺减少抗血栓治疗不足来增进患者健康与安全。

12精神心理护理 (1篇)

临床研究 (1篇)

EClinicalMedicine IF 12.8 2026-10 PMID: 42774588
Palliative psychiatry applies palliative care principles to the mental health care of people experiencing severe and persistent mental illness (SPMI), with the aim of improving quality of life and alleviating suffering. As debates about assisted dying (AD) for mental illness expand globally, questions have emerged about how palliative psychiatry relates to AD. This scoping review, guided by Arksey and O'Malley's scoping review framework, maps the scholarly and grey literature on the relationship between palliative psychiatry and AD. Database searches were run on April 30, 2025, and updated on September 2, 2025. Data were analyzed using descriptive numerical analysis and qualitative content analysis. Among the 50 included publications, 15 characterized palliative psychiatry and AD as separate practices with distinct goals, while 13 proposed palliative psychiatry as an alternative care pathway to AD and care-as-usual. The literature positions the relationship between palliative psychiatry and AD along a spectrum, from equivalent to differentiated, though most publications treat them as distinct. Future research should clarify the definition and practice of palliative psychiatry, and examine whether, and how, it may offer a quality of life-oriented alternative care pathway. The Canadian Institutes of Health Research provided financial support for this review. The funder had no role in study design; data collection, analysis, and synthesis; report writing; and the decision to submit the paper for publication.
中文摘要:姑息精神医学将姑息照护原则应用于经历严重且持续性精神疾病(SPMI)者的精神卫生照护,旨在改善生活质量和减轻痛苦。随着全球范围内针对精神疾病的辅助死亡(AD)辩论不断扩大,关于姑息精神医学与AD之间关系的问题也随之出现。本范围综述以Arksey和O'Malley的范围综述框架为指导,梳理关于姑息精神医学与AD之间关系的学术文献和灰色文献。数据库检索于2025年4月30日进行,并于2025年9月2日更新。采用描述性数值分析和定性内容分析对数据进行分析。在纳入的50篇出版物中,15篇将姑息精神医学与AD描述为具有不同目标的独立实践,而13篇提出将姑息精神医学作为AD和常规照护之外的替代照护路径。文献将姑息精神医学与AD之间的关系置于从等同到区分的谱系上,尽管大多数出版物将二者视为不同。未来研究应阐明姑息精神医学的定义与实践,并考察其是否以及如何能够提供一种以生活质量为导向的替代照护路径。加拿大卫生研究院为本综述提供了资金支持。资助方在研究设计;数据收集、分析和综合;报告撰写;以及决定投稿发表方面均无作用。